[A clinical study of rokitamycin dry syrup in pediatric infections].
A clinical study on rokitamycin (RKM) dry syrup was carried out and the results obtained are summarized as follows: 1. Good clinical responses were achieved with 30-40 mg/kg/day dose of RKM dry syrup. 2. Diagnostically, acute bronchitis and bronchial pneumonia responded better than other diseases examined. 3. The efficacy rate was low in the group of patients complicated by bronchial asthma.
Fukushima
N
N
Department of Pediatrics, Sapporo City General Hospital.
Wagatsuma
Y
Y
Takase
A
A
Ishikawa
A
A
Hattori
T
T
D000284:Administration, Oral; D000293:Adolescent; D001991:Bronchitis / Q000188:drug therapy*; D001996:Bronchopneumonia / Q000188:drug therapy*; D002648:Child; D005260:Female; D006801:Humans; D007933:Leucomycins / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D015644:Miocamycin / Q000031:analogs & derivatives*
D007933:Leucomycins; D015644:Miocamycin; C033383:rokitamycin